Skip to content
The Joe Rogan ExperienceThe Joe Rogan Experience

Joe Rogan Experience #2462 - Aaron Siri

Aaron Siri is an attorney and managing partner of Siri & Glimstad LLP, where he focuses on civil litigation, constitutional law, and vaccine-related injury claims. He is the host of the podcast “Informed with Aaron Siri” and the author of “Vaccines, Amen: The Religion of Vaccines.” https://www.aaronsiri.substack.com https://www.youtube.com/@AaronSiriSG https://www.aaronsiriofficial.com https://www.sirillp.com Perplexity: Download the app or ask Perplexity anything at https://pplx.ai/rogan. Montana Knife Company - working knives for working people. Head over to https://montanaknifecompany.com to shop now.  This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE

Joe RoganhostAaron Siriguest
Mar 3, 20262h 36mWatch on YouTube ↗

CHAPTERS

  1. From mainstream trust to skepticism after COVID: why question vaccines now?

    Joe and Aaron open by contrasting their former “mainstream” trust in vaccines with the shift brought on by COVID-era messaging, mandates, and what they describe as propaganda. They frame vaccine debate as socially policed—where dissent is labeled irrational—creating “religion-like” dynamics and cognitive dissonance.

  2. The 1986 Vaccine Act and the unique liability shield for vaccine makers

    Aaron argues vaccines are unlike any other product because manufacturers are largely shielded from design-defect lawsuits. He explains the National Childhood Vaccine Injury Act of 1986 as a turning point that, in his view, removed a key market mechanism that drives safety improvements in other industries.

  3. How products become safer: market incentives, lawsuits, and punitive damages (Pinto/Vioxx)

    They debate whether corporate self-interest reliably ensures safety, using Vioxx and the Ford Pinto as examples. Aaron argues liability—especially punitive damages—corrects scenarios where companies might otherwise accept harm as a cost of doing business, and he claims vaccines lack this corrective force.

  4. Steel-manning the pro-immunity argument—and Aaron’s rebuttal

    Joe presents the best case for shielding vaccine makers: vaccines are essential and frivolous litigation could threaten supply. Aaron counters that other critical products and high-risk drugs survive without blanket immunity through safer design and robust warnings, and questions why immunity persists decades after licensure.

  5. Clinical trial standards: placebo controls, follow-up duration, and vaccine licensure claims

    Aaron contrasts multi-year placebo-controlled trials for top-selling drugs with what he says are much shorter vaccine safety follow-ups. He claims routine injected childhood vaccines were not licensed with inert placebo-controlled trials and frames this as a key evidence gap driving public distrust.

  6. Rethinking “vaccines saved everyone”: measles deaths, mortality decline, and cultural memory

    They challenge the common narrative that mass death would occur without vaccination by focusing on measles. Aaron cites CDC-era mortality numbers (hundreds of deaths yearly pre-vaccine) and argues most mortality decline preceded vaccines due to sanitation, living standards, and medical care, illustrated by a Brady Bunch measles clip.

  7. Possible benefits of childhood infections: cancer/cardiovascular associations and “inconvenient” studies

    Aaron cites epidemiological studies suggesting associations between having measles/mumps and lower later-life rates of certain cancers and cardiovascular deaths. Joe explores possible mechanisms (hormesis/immune training), while Aaron stresses that data can be true even if not intuitively satisfying.

  8. Transmission vs non-transmission vaccines: measles/chickenpox versus pertussis/hep B

    Aaron differentiates vaccines that can reduce transmission (MMR, chickenpox) from those he says do not, arguing this changes risk-benefit and policy logic. They discuss the claim that pertussis vaccination may increase spread and focus on the controversy around giving newborns hepatitis B vaccine.

  9. Hepatitis B policies, Denmark comparison, and the Vaccine Injury Compensation Program (VICP)

    Aaron compares U.S. universal infant Hep B vaccination to Denmark’s targeted approach for infants of Hep B-positive mothers, claiming similar pediatric Hep B rates but different vaccine-exposure risks. He explains the VICP as the alternative to normal litigation and criticizes its structure and compensation limits.

  10. COVID censorship, FOIA battles, and “malinformation”: when primary documents get labeled misinformation

    They recount social-media removals and government-platform coordination during COVID, including Aaron’s lawsuit seeking Pfizer licensing documents and his claim that quoting those documents was flagged as misinformation. The conversation broadens to “malinformation,” media incentives, and why censorship should alarm people across politics.

  11. Lockdowns and civil liberties: mandates, rights, and the ratchet effect of government power

    Aaron argues the most shocking COVID overreach was public compliance with open, explicit restrictions on movement and assembly. He frames medical liberty as foundational, warns that mandates are cheaper than persuasion, and describes a historical pattern where authorities escalate from recommendations to coercion and censorship.

  12. Institutions, money, and regulatory capture: revolving doors, agencies writing ‘laws,’ and pharma influence

    They discuss how federal agencies create large volumes of binding regulations and how industries can capture regulators via lobbying and revolving-door career incentives. Aaron cites high-profile examples (e.g., CDC leadership moving to pharma) and argues capture is systemic rather than purely “evil intent.”

  13. From vaccines to broader “belief systems”: academia groupthink, climate analogies, search manipulation, and AI pitfalls

    The conversation widens to how institutions enforce orthodoxies: academia incentives, media narratives, and tech platforms shaping information. They discuss curated search results, polarization via social media, and Aaron’s caution that AI tools can fabricate citations, requiring verification through primary sources.

  14. Autism and vaccines: FOIA settlement, lack of studies for early-life shots, and deposition claims

    Aaron presents his most specific claim: that CDC assertions that “vaccines don’t cause autism” are not supported by studies for vaccines administered in the first six months of life. He describes a FOIA lawsuit ending in a settlement listing studies (mostly not addressing early-life vaccines), references depositions with prominent vaccinologists, and cites a single Hep B–autism study he says shows a significant association.

  15. Closing: incentives without guardrails, business-model critique, and why transparency matters

    They conclude by returning to incentives: immunity, mandates, government purchase programs, and public messaging create what they call a uniquely distorted market. They argue transparency and accountability would reduce distrust, and close with Aaron promoting his book and audiobook while Joe emphasizes the importance of open debate.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.

Add to Chrome